Current concepts in malignant hyperthermia.
1From the Neurological Department, KA Rudolfstiftung 1030 Vienna, Austria.
Journal of Clinical Neuromuscular Disease
|December 17, 2008
Summary
Malignant hyperthermia crisis (MHC) is a rare, life-threatening reaction to anesthesia in susceptible individuals. Early recognition and specialized care, including dantrolene, are crucial for managing MHC and preventing mortality.
Area of Science:
- Anesthesiology
- Pharmacology
- Genetics
Background:
- Malignant hyperthermia (MH) is a rare, pharmacogenic myopathy.
- It manifests as a potentially lethal MH crisis (MHC) during or after general anesthesia in genetically predisposed individuals (MH susceptible).
- MHC can also occur in patients with central core disease and MCH-like crises in other myopathies.
Purpose of the Study:
- To provide a comprehensive overview of Malignant Hyperthermia (MH).
- To discuss diagnosis, triggers, and management of MH crisis (MHC).
- To emphasize the importance of specialized consultation and education for reducing MH-related morbidity and mortality.
Main Methods:
- Review of existing literature on Malignant Hyperthermia.
- Discussion of diagnostic criteria, including the in vitro caffeine-halothane contracture test (CHCT).
- Outline of current therapeutic strategies for MH crisis.
Main Results:
- The caffeine-halothane contracture test remains the gold standard for diagnosing MH susceptibility.
- Volatile anesthetics and depolarizing muscle relaxants are primary triggers of MHC.
- Prompt treatment involving discontinuation of triggers, dantrolene, and supportive care is essential for MHC management.
Conclusions:
- MH susceptibility requires careful preoperative assessment and awareness among anesthesiologists and neurologists.
- Specialist consultation post-MHC is vital for diagnosis, management, and family counseling.
- Further research into the genetic basis of MH and development of new diagnostic tests are needed to improve patient outcomes.
Related Concept Videos
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:25Types of Fever
Fever can be triggered by several factors, including infections, nervous system disorders, certain cancers, blood diseases like leukemia, embolism, thrombosis, heatstroke, dehydration, surgical trauma, crushing injuries, and allergic reactions.
Here are the different types of fever:
Here are the different types of fever:
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...